CompletedNot Applicable

Effect of Pulsed Signal Therapy in Patella Chondromalacia

Brazil41 participantsStarted 2012-11

Plain-language summary

PST (pulsed signal therapy) is a unique form of pulsed electromagnetic field therapy (PEMF) for stimulating healing of damaged structures such as cartilage, bones and soft tissues. The physical effect of the pulsed electromagnetic field (PEMF) has been focus of research in various studies, with cartilage being the most studied, and which has demonstrated an increase in the synthesis of proteoglican and collagen in vitro. This is an randomized, controlled and double blind clinical trial. The main objective is to evaluate clinical improvement regarding anterior knee pain after PST intervention in patients with patellar condropathy.

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patellofemoral pain syndrome without tibiofemoral and trochlear chondral degeneration according to magnetic resonance imaging (MRI); * presence of patellar chondropathy confirmed by MRI; * not having started using direct action drugs on the cartilage in the last 6 months; * absence of prior surgery on the studied knee; * absence of invasive procedures, such as knee infiltration, in the previous 12 months; * absence of disease in the contralateral limb that would cause an excessive burden on the studied limb; and * absence of contraindications to performing PST, including a pacemaker, cancer, infectious disease activity, severe heart failure, arrhythmias, angina, epilepsy and pregnancy.

What they're measuring

Clinical improvement - Kujala score

Timeframe: 12 months

Trial details

NCT IDNCT02012413

SponsorUniversity of Sao Paulo General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-03

View on ClinicalTrials.gov More Patella Chondromalacia trials